1. Home
  2. CPIX vs PFO Comparison

CPIX vs PFO Comparison

Compare CPIX & PFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

N/A

Current Price

$5.19

Market Cap

98.3M

Sector

Health Care

ML Signal

N/A

Logo Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

PFO

Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

N/A

Current Price

$8.62

Market Cap

110.8M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CPIX
PFO
Founded
1999
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
98.3M
110.8M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
CPIX
PFO
Price
$5.19
$8.62
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 128.9K
32.8K
Earning Date
11-10-2026
01-01-0001
Dividend Yield
N/A
★ 6.51%
EPS Growth
★ 58.70
N/A
EPS
N/A
★ N/A
Revenue
★ $42,010,949.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 16.75
N/A
52 Week Low
$1.85
$8.42
52 Week High
$9.28
$9.80

Technical Indicators

Market Signals
Indicator
CPIX
PFO
Relative Strength Index (RSI) 42.65 53.51
Support Level $3.08 $8.42
Resistance Level $6.32 $9.24
Average True Range (ATR) 0.87 0.09
MACD -0.13 0.03
Stochastic Oscillator 23.50 84.61

Price Performance

Historical Comparison
CPIX
PFO

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

Share on Social Networks: